177 related articles for article (PubMed ID: 37934255)
1. Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615.
Shan Y; Xia T; Xie W; Wan W; Wu N; Yuan Z; Hu Q; Chen Z; Li C; Wu L; Wu W; Cai T; Xiang Y; Bai L; Li Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17781-17793. PubMed ID: 37934255
[TBL] [Abstract][Full Text] [Related]
2. Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma.
Tao H; Zhang Y; Yuan T; Li J; Liu J; Xiong Y; Zhu J; Huang Z; Wang P; Liang H; Zhang E
Aging (Albany NY); 2022 Feb; 14(3):1473-1491. PubMed ID: 35148283
[TBL] [Abstract][Full Text] [Related]
3. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
[TBL] [Abstract][Full Text] [Related]
4. Modular signature of long non-coding RNA association networks as a prognostic biomarker in lung cancer.
Li A; Yu WH; Hsu CL; Huang HC; Juan HF
BMC Med Genomics; 2021 Dec; 14(Suppl 3):290. PubMed ID: 34872564
[TBL] [Abstract][Full Text] [Related]
5. Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma.
Xiao L; Huang Y; Li Q; Wang S; Ma L; Fan Z; Tang Z; Yuan X; Liu B
Front Mol Biosci; 2022; 9():976878. PubMed ID: 36060239
[No Abstract] [Full Text] [Related]
6. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.
Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X
Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.
Yalimaimaiti S; Liang X; Zhao H; Dou H; Liu W; Yang Y; Ning L
BMC Bioinformatics; 2023 Mar; 24(1):81. PubMed ID: 36879187
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response.
Gao M; Wang M; Chen Y; Wu J; Zhou S; He W; Shu Y; Wang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):171. PubMed ID: 38558328
[TBL] [Abstract][Full Text] [Related]
10. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
[TBL] [Abstract][Full Text] [Related]
11. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
12. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
13. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
14. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
15. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ
J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578
[TBL] [Abstract][Full Text] [Related]
17. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis-related long non-coding RNAs in lung cancer through a novel tumor mesenchymal score.
Yang D; Niu Y; Ni H; Leng J; Xu X; Yuan X; Chen K; Wu Y; Wu H; Lu H; Xu J; Wang L; Jiang Y; Cui D; Hu J; Xia D; Wu Y
Pathol Res Pract; 2022 Sep; 237():154018. PubMed ID: 35914372
[TBL] [Abstract][Full Text] [Related]
19. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
20. A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma.
Cui Y; Wang X; Zhang L; Liu W; Ning J; Gu R; Cui Y; Cai L; Xing Y
Front Oncol; 2022; 12():974614. PubMed ID: 36185284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
